Recent developments of interest in cardiovascular medicine
After ransomware attacks or other hacks, hospitals' heart attack mortality rates are higher, speculated to be due to delays in care from stronger passwords and other cybersecurity remediation. (PBS.org)
Subcutaneous implantable cardioverter-defibrillators may have a special advantage for adults with congenital heart disease, who may have limited or no venous access to the heart, but nearly half aren't eligible, a study found. (MedRxiv)
A video game for interventional cardiologists teaches intravascular ultrasound interpretation and how to use (sponsors') equipment. (Medical Design & Outsourcing)
The new year will ring in universally lower evolocumab (Repatha) prices -- $5,850/year for all insurers, not just some. (Market Watch)
An obscure programmer at Nerds on Call in Normal, Illinois has been one of the key heroes in decrypting ransomware. ProPublica has this profile.
For significant bleeds after cardiac surgery with cardiopulmonary bypass in patients with low fibrinogen levels, fibrinogen concentrate and cryoprecipitate were on par for reducing transfused blood product use in the FIBRES trial. (JAMA)
Some Get With the Guidelines data is now publicly reported, for hospitals that opt in, with the idea of national hospital rankings for stroke and cardiovascular disease treatment, the American Heart Association announced.
Frailty assessment is cost-efficient in evaluating older patients for coronary artery bypass surgery but it might be hard to find someone to do it, Cardiovascular Business reports.
The CoFI controlled flow infusion system got FDA breakthrough device designation for diagnosing coronary microcirculation immediately after percutaneous coronary intervention and for controlled infusion of therapeutic agents, CorFlow Therapeutics announced.
Read the original article on Medpage Today: Data Security Bad for MI Survival? Best Post-Op Bleed Tx; GWTG Public Reporting